New bandage could replace messy ointments after face surgery
NCT ID NCT07075159
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a hydrocolloid dressing (a special bandage) applied right after oculofacial surgery to see if it can replace antibiotic ointment. Twenty adults who have had Mohs surgery or other facial reconstruction will wear the dressing for one week. The goal is to simplify post-operative care and reduce the burden on patients.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Hydrocolloid wound dressing (DuoDERM EXTRA THIN)
- What this could lead to
- If it works, this could simplify wound care after facial surgery, reducing the need for daily ointment application and follow-up visits.
- What could go wrong
- This is a very small, early-phase study with only 20 participants. The dressing may not heal wounds as well as standard care, and there is a risk of allergic reaction to the dressing materials.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 20 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Feb 2025
- Expected to finish
-
Sep 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 100 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients \>18 years of age * follow-up at specified intervals (1 week/6 week/3 months) in an office setting * can give informed consent * no patients will be excluded on the basis of gender, ethnicity, or religious background Exclusion Criteria: * Patients \<18 years of age or \>100 * allergy to pectin, gelatin, and sodium carboxymethylcellulose * adults with impaired consent capacity * incarcerated individuals.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Mohs micrographic surgery are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
University of Kentucky
RECRUITINGLexington, Kentucky, 40508, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood tests may reveal hidden healing power of bone marrow stem cells
- Can age slow down dental healing? a study investigates
- Can a seaweed extract help bones regrow in the jaw?
- Can a Blood-Based clot improve mouth healing in people with obesity?
- Seaweed gel may speed healing after dental implants — a trial puts it to the test
- Can an oxygen gel heal medication-damaged jaw bone better than a blood-derived patch?